A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
Description
Brief Summary
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual
clinical practice. TARGET-HCC will create a research registry of participants with HCC within
academic and community real-world practices in order to assess the safety and effectiveness
of the entire spectrum of current and future therapies across diverse populations.
Phase
N/AInclusion and Exclusion Criteria
- Male or female patients, age ≥18 years
- Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)
- Inability to provide written informed consent
Sites
Please contact the trial administrator to learn more about where you can participate in this trial. Please use the contact form on the right side.